SELLAS Life Sciences Group, Inc. Share Price

SELLAS Life Sciences Group, Inc. Share Price

NASDAQ: SLS | Small Cap
$9.68
-$0.50 (-4.91%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

SELLAS Life Sciences Group, Inc. Stock Performance

Open
$9.60
Prev. Close
$10.18
Circuit Range
N/A
Day Range
$9.30 - $9.76
Year Range
$1.39 - $15.86
Volume
1,82,810
Average Traded
$9.53

SELLAS Life Sciences Group, Inc. Share Price Today

As of 1 November 2026, SELLAS Life Sciences Group, Inc.'s share price is $9.68. The stock opened at $9.60, compared to its previous close of $10.18. During today's trading session, SELLAS Life Sciences Group, Inc.'s share price traded between $9.30 and $9.76, with an average price of $9.53. Over the past 52 weeks, the stock has recorded a high of $15.86 and a low of $1.39. In terms of performance, SELLAS Life Sciences Group, Inc.'s share price has risen by 96.25% over the last six months and is up 433.06% on a year-on-year basis.

SELLAS Life Sciences Group, Inc. Share Price Chart

Line chart of the SELLAS Life Sciences Group, Inc. price trend over the selected period. The price fell overall, ranging from 9.31 to 9.74, ending at 9.68.
$9.30$9.76
L
Show Current Price
H

SELLAS Life Sciences Group, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.06B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.16
Revenue (TTM)
$0.00
Return On Equity (TTM)
-23.58%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-41.53%

SELLAS Life Sciences Group, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.79-$7.66-$8.41-$9.61
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-12.81%-9.79%-14.27%

SELLAS Life Sciences Group, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$1.00$0.00$0.00$0.00
Net Profit-$41.30-$37.34-$30.88-$26.86
Net Profit Margin-4130.00%N/AN/AN/A
Income ChangeN/A9.59%17.30%13.02%

About SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

SELLAS Life Sciences Group, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$12.16
$9.69
-21.55%
Sep 2026
$13.07
$12.35
-18.78%
Aug 2026
$9.94
$15.20
+52.08%
Jul 2026
$14.06
$9.99
-32.33%
Jun 2026
$9.09
$14.77
+58.73%
May 2026
$4.93
$9.30
+88.74%
Apr 2026
$4.28
$4.93
+16.82%
Mar 2026
$4.67
$4.22
-14.66%
Feb 2026
$3.69
$4.95
+31.17%
Jan 2026
$4.39
$3.77
-0.40%
Dec 2025
$1.58
$3.79
+132.92%
Nov 2025
$1.84
$1.63
-10.47%

SLS Share Price FAQs